5. References

  1. IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Available at: https://www-micromedexsolutions-com.libproxy.uthscsa.edu/ (cited: February 21, 2022).
  2. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2022. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed February 21, 2022.
  3. Atorvastatin tablets (Lipitor®) package insert. Parke-Davis Division of Pfizer, November 2021.
  4. Fluvastatin capsules package insert. Teva Pharmaceuticals USA, Inc., August 2020.
  5. Fluvastatin extended-release tablets (Lescol® XL) package insert. Novartis Pharmaceuticals Corporation, July 2021.
  6. Lovastatin immediate-release tablets package insert. Teva Pharmaceuticals USA, Inc., August 2020.
  7. Lovastatin extended-release tablets (Altoprev®) package insert. Covis Pharma US, Inc., December 2021.
  8. Pitavastatin calcium tablets (Livalo®) package insert. Kowa Pharmaceuticals America, Inc., May 2019.
  9. Pravastatin tablets (Pravachol®) package insert. Accord Healthcare Inc., May 2021.
  10. Rosuvastatin tablets (Crestor®) package insert. AstraZeneca, September 2020.
  11. Simvastatin tablets (Zocor®) package insert. Merck & Co., Inc., December 2020.
  12. Simvastatin oral suspension (FloLipid®) package insert. Salerno Pharmaceuticals, February 2022.
  13. Pitavastatin magnesium (Zypitamag™) package insert. Medicure Pharma, September 2020.
  14. Rosuvastatin sprinkle capsules (Ezallor Sprinkle™) package insert. Sun Pharmaceutical Industries, September 2020.
  15. Ezetimibe/simvastatin tablet (Vytorin®) package insert. Merck & Co., Inc., December 2020.
  16. Amlodipine/atorvastatin tablets (Caduet®) package insert. Pfizer, March 2021.
  17. Ezetimibe/ Rosuvastatin (Roszet®) package insert. Althera Pharmaceuticals, LLC. September 2021.
  18. Tobert JA, East C, Alivizatos PA, Grundy SM, Jones PH, Farmer JA.  Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation. N Engl J Med. 1988;318:47-8.
  19. Spach DH, Bauwens JE, Clark CD, Rhabdomyolysis associated with lovastatin and erythromycin use. West J Med. 1991;154:213-15.
  20. Pierce LR, Wysowski DK, Gross TP. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA. 1990;264:71-5.
  21. Neuvonen PJ, Jalava KM. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther. 1996;60:54-61.
  22. Neuvonen PJ. Niemi M. Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther. 2006;80:565-81.
  23. Bottorff MB. Statin safety and drug interactions: clinical implications. Am J Cardiol. 2006;97(8A):27C-31C.
  24. Armitage J. The safety of statins in clinical practice. Lancet. 2007;37:1781-90.
  25. Anonymous. Which statin, what dose? Drug Ther Bull. 2007;45:33-7.
  26. Neuvonen PJ, Niemi N, Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther. 2006;80:565-81.
  27. Shitara Y, Sugiyama Y.  Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug–drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther. 2006;112:71-105.
  28. Dixit V, Hariparsad N, Li F, et al. Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions. Drug Metab Dispos. 2007;35:1853-9.
  29. Kiser JJ, Gerber JG, Predhomme JA, et al. Drug/drug interaction between loprenavir/ritonavir and rosuvastatin in healthy volunteers. J Acquir Immune Defic Syndr.  2008;47:570-8.
  30. Busti AJ, Bain AM, Hall RG II, et al. Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin. J Cardiovasc Pharmacol. 2008;51:605-10.
  31. Winston A, Boffito M. The management of HIV-1 protease inhibitor pharmacokinetic interactions. J Antimicrob Chemother. 2005;56:1-5.